Does ENZALUTAMIDE Cause Product availability issue? 262 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 262 reports of Product availability issue have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.5% of all adverse event reports for ENZALUTAMIDE.
262
Reports of Product availability issue with ENZALUTAMIDE
0.5%
of all ENZALUTAMIDE reports
39
Deaths
111
Hospitalizations
How Dangerous Is Product availability issue From ENZALUTAMIDE?
Of the 262 reports, 39 (14.9%) resulted in death, 111 (42.4%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Product availability issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 262 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Product availability issue?
RUXOLITINIB (2,142)
LISDEXAMFETAMINE DIMESYLATE (1,530)
CERTOLIZUMAB PEGOL (1,381)
VEDOLIZUMAB (636)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610)
METHYLPHENIDATE (444)
SECUKINUMAB (399)
BIMEKIZUMAB-BKZX (364)
LACOSAMIDE (359)
BRIVARACETAM (324)
Which ENZALUTAMIDE Alternatives Have Lower Product availability issue Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE